In May 2023, ELF and ERS provided feedback to the EU consultation on tobacco control.
Last month, ELF and ERS answered the European Commission’s public consultation on the evaluation of legislative framework for tobacco control. Based on scientific research findings, ELF and ERS got the opportunity to once more voice their viewpoint on the risks of novel and emerging tobacco and nicotine products, as well as to propose a direction for future EU and national regulations.
When it comes to novel and emerging tobacco and nicotine products, ELF and ERS provided 7 reasons why they are not risk-free:
ELF and ERS proposed the following guidelines for future regulation:
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.